Home » Newsletters » BioWorld

BioWorld

Jan. 19, 1993

View Archived Issues

GENSIA APPLIES TO MARKET ARASINE IN EUROPE

MYCOGEN DEAL WITH FORAGE GENETICS

GI LICENSES FACTOR IX PROTEIN

CYTOGEN SHIPS ONCOSCINT

CANGUARD PACT WITH ATHENA

CHIRON ESTABLISHES MARKETER

AIS LICENSES ANTI-CD34 ANTIBODIES

APPLIED BIOSCIENCE CONSOLIDATES COMPANIES

PHOTODYNAMIC SKIN TUMOR TREATMENT 'EFFECTIVE'

GLAXO EXPANDS STAKE IN BIOCHEM PHARMA

VESTAR DONATES DRUG TO KS PATIENTS

SUGEN JOINS FORCES WITH SELECTIDE

CENTOCOR HALTS TRIALS; STOCK PLUMMETS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...